StockNews.com initiated coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research note issued to investors on Friday. The brokerage issued a hold rating on the specialty pharmaceutical company’s stock. Separately, Alliance Global Partners assumed coverage on shares of Lipocine in a report on Tuesday, September 24th. They issued a “buy” rating and […]

StockNews.com started coverage on shares of Evoke Pharma (NASDAQ:EVOK – Free Report) in a report released on Wednesday. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Evoke Pharma Trading Down 2.1 % NASDAQ EVOK opened at $4.37 on Wednesday. The company has a 50-day moving average price of $4.52 and a […]